In the Original Investigation “Phase 2 Evaluation of Neoadjuvant Intensity-Modulated Radiotherapy in Centrally Located Hepatocellular Carcinoma: A Nonrandomized Controlled Trial”1 published online October 5, 2022, there was an error in the order that the authors were listed in the byline. Jianxiong Wu, MD, should be listed before Weihu Wang, MD. The article has been corrected online.
Reference
- 1.Wu F, Chen B, Dong D, et al. Phase 2 evaluation of neoadjuvant intensity-modulated radiotherapy in centrally located hepatocellular carcinoma: a nonrandomized controlled trial. JAMA Surg. Published online October 5, 2022. doi: 10.1001/jamasurg.2022.4702 [DOI] [PMC free article] [PubMed] [Google Scholar]